Single-use Bronchoscopes Market Expands with Advances in Sterility and Safety


 The global single-use bronchoscopes market has demonstrated remarkable growth over recent years, expanding at a compound annual growth rate (CAGR) of 19.2% from 2019 to 2024, reaching a valuation of US$ 473.6 million in 2024. According to the latest analysis by Persistence Market Research, the market is projected to accelerate further at a CAGR of 23.6%, attaining a value of US$ 2,390.7 million by the end of 2032.

In 2024, sales of single-use bronchoscopes accounted for 28.2% of the overall global single-use endoscopes market. The COPD indication segment emerged as the largest application area, capturing 29.5% of the market. This rapid adoption is underpinned by growing awareness about infection prevention, rising incidence of lung cancer, and the shift toward minimally invasive procedures.

Clinical Significance of Bronchoscopy

Bronchoscopy remains a critical diagnostic and therapeutic procedure for detecting pulmonary abnormalities, infections, neoplasms, and hemoptysis. It plays a key role in therapeutic applications, including clearing airway obstructions, managing secretions, and alleviating mucus plugging. The advent of single-use bronchoscopes offers significant advantages over reusable devices, notably their sterile, ready-to-use nature, which drastically reduces the risk of infection transmission.

Growth Drivers

Rising Burden of Lung Diseases

The increasing prevalence of lung cancer and chronic obstructive pulmonary disease (COPD) is a major factor driving demand for single-use bronchoscopes. According to the World Cancer Research Fund International, lung cancer ranks as the second most common cancer globally, with over 2.2 million new cases in 2020. Single-use bronchoscopes are becoming indispensable in procedures such as bronchoalveolar lavage (BAL) and airway inspections, offering a safe and cost-effective alternative to reusable scopes.

Impact of COVID-19

The COVID-19 pandemic significantly accelerated the adoption of single-use bronchoscopes as healthcare professionals prioritized infection control and patient safety. Global medical bodies, particularly in the United States, recommended the use of disposable devices for bronchoscopies to mitigate cross-contamination risks during the pandemic.

Shift to Minimally Invasive Techniques

A global trend toward minimally invasive diagnostics and therapeutic interventions is fueling demand. Single-use devices not only enhance patient safety but also reduce operational downtime associated with cleaning and sterilizing reusable equipment.

Market Restraints

Despite the rapid growth trajectory, the market faces environmental concerns over the non-biodegradable waste generated by disposable medical devices. Additionally, in certain advanced procedures, reusable bronchoscopes remain preferred due to their specialized capabilities. Addressing these challenges through biodegradable materials and recycling initiatives could unlock further growth opportunities.

Market Size Outlook

The single-use bronchoscopes market is projected to grow from US$ 564.5 million in 2025 to US$ 2,390.7 million by 2032, reflecting a CAGR of 22.9% over this period. The top five countries are expected to collectively hold 51.3% of the market share in 2032.

Country-wise Insights

United States: A Global Leader in Adoption

The United States held a 30.2% share of the global market in 2024, driven by a high annual volume of approximately 500,000 bronchoscopies. The U.S. Food and Drug Administration (FDA) has issued guidance encouraging the use of single-use bronchoscopes in scenarios with elevated infection risks, including COVID-19 care. This regulatory support, combined with advanced healthcare infrastructure, is cementing the U.S. position as a highly lucrative market.

China: Geriatric Population Fuels Growth

China accounted for 7.9% of the global market in 2024. The country’s growing elderly population, rising lung cancer incidence, and governmental approval of disposable bronchoscopes are major drivers. In 2022, the Chinese Medical Journal reported a projected 4.82 million cancer cases, with lung cancer being the most prevalent. Disposable scopes have improved access to bronchoscopy procedures among elderly patients by minimizing discomfort and infection risks.

Germany: Focus on Infection Prevention

Germany captured 4.3% of the market in 2024, supported by a strong emphasis on infection control and chronic disease management. Technological advancements and collaborations between manufacturers and research institutions are shaping the market. In 2024, Zsquare, a developer of high-performance single-use endoscopes, received the German Innovation Award, signaling increased recognition of innovative solutions in this space.

Category-wise Insights

By Type

Regular-sized single-use bronchoscopes commanded 34.8% of the market in 2024. Their popularity is attributed to their suitability for a wide range of patients, including teens and adults with chronic lung disorders. The broad availability of these scopes further consolidates their dominance.

By Usage

Bronchoscopy suites accounted for 44.5% of market share in 2024. These dedicated environments are preferred due to their advanced equipment, skilled personnel, and optimized procedural setups. Controlled conditions within suites enhance diagnostic accuracy and procedural safety.

By Indication

COPD remained the leading indication segment with 29.5% market share in 2024. According to the WHO, COPD caused 3.23 million deaths in 2019, ranking as the third leading cause of death globally. The disease burden is particularly high in low- and middle-income countries, while tobacco use remains a major contributing factor in developed economies.

Competitive Landscape

The single-use bronchoscopes market is characterized by strong competition and rapid innovation. Leading players are focused on enhancing imaging quality, maneuverability, handling, and scope durability. They are also expanding product portfolios to cater to diverse clinical needs.

Notable developments include:

  • Olympus Corporation announced clearance for its H-SteriScope™ Single-use Bronchoscopes in April 2021, targeting advanced diagnostic and therapeutic procedures.

  • Ambu A/S received FDA 510(k) approval in July 2022 for its aScope™ 5 Broncho family of sterile, single-use bronchoscopes.

  • Zsquare earned the German Innovation Award 2024 for its high-performance single-use endoscopes.

Prominent companies in the market include:

  • AMBU A/S

  • Boston Scientific Corporation

  • Fujifilm Holdings Corporation

  • Karl Storz GmbH & Co. KG

  • NeoScope Inc.

  • Olympus Corporation

  • PENTAX Medical

  • Endoso Life

  • Innovex Medical Co., Ltd.

  • Hunan Vathin Medical Instrument Co., Ltd.

  • Zhejiang Geyi Medical Instrument Co., Ltd.

Future Outlook

With infection prevention emerging as a cornerstone of modern healthcare, the single-use bronchoscopes market is expected to witness sustained momentum. The transition toward biodegradable materials, coupled with technological innovations, will address current environmental concerns and broaden adoption. Furthermore, the growing emphasis on patient safety, coupled with the rising global burden of respiratory diseases, positions the market for substantial long-term growth.

By 2032, as healthcare systems worldwide continue to invest in advanced diagnostic tools and minimally invasive techniques, single-use bronchoscopes are likely to become a standard of care in bronchoscopy procedures, reshaping clinical practice and driving transformative change across pulmonary medicine.

Read Related Reports:

Combination Therapies In Aesthetics Market

Cardiac Surgery Devices Market

Cloudbased Drug Discovery Platform Market

Elastomeric Infusion Pumps Market

Comments

Post a Comment

Popular posts from this blog

Legionella Testing Market Expansion Supported by Rising Awareness of Legionnaires’ Disease

Image
  The global legionella testing market , which is currently valued at USD 322.4 million in 2026, is projected to grow substantially, reaching USD 547.8 million by 2033. This robust growth represents a compound annual growth rate (CAGR) of 7.9% from 2026 to 2033. Several factors, including the rising incidence of Legionnaires' disease and increasing government regulations around water safety management, are fueling this expansion. As the prevalence of waterborne diseases like Legionnaires' disease escalates globally, the demand for reliable and efficient testing methods continues to rise, creating significant opportunities within the market. Market Dynamics: Drivers and Challenges Driver: Rising Incidence of Legionnaires' Disease and Aging Infrastructure One of the primary drivers of the legionella testing market’s growth is the increasing number of Legionnaires' disease cases globally. According to the Centers for Disease Control and Prevention (CDC), in the United Sta...
Read more

Antibody Testing Market Expands Amid Rising Demand for Accurate COVID-19 Screening Solutions

 The global antibody testing market is set for substantial expansion over the next decade, driven by growing demand for accurate diagnostic tools, increasing prevalence of infectious and chronic diseases, and significant advancements in immunodiagnostic technologies. According to the latest industry analysis, the global antibody testing market size is expected to be valued at US$9.4 billion in 2025 and projected to reach US$16 billion by 2032 , growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2025 to 2032. Market Overview Antibody testing, also known as serology testing, plays a crucial role in detecting the presence of antibodies in the blood, indicating an immune response to infections, vaccines, or autoimmune disorders. Over the past few years, the market has witnessed accelerated growth due to the increased demand for diagnostic tests following the COVID-19 pandemic. The rise in awareness regarding preventive healthcare, increasing healt...
Read more

UAE Health Check-up Market Set for Robust Growth Driven by Preventive Healthcare Initiatives

Image
  The UAE health check-up market is on a strong growth trajectory, projected to reach US$ 113.8 million by 2032, up from US$ 77.0 million in 2025, reflecting a compound annual growth rate (CAGR) of around 5.0% during the forecast period. This growth reflects a notable transformation in the UAE’s healthcare landscape, where residents are increasingly shifting from reactive treatment approaches to proactive, preventive care. Regular health check-ups are now being recognized as essential components of personal well-being rather than optional services. The growing focus on lifestyle disease management, government-led health campaigns, mandatory screenings for residency and employment, and innovative diagnostic technologies are driving this trend, particularly in urban hubs like Abu Dhabi and Dubai. Key Industry Highlights General health check-ups are expected to hold a dominant share in 2025, driven by the adoption of wellness programs among corporates. Companies are increasingly inco...
Read more